In this webinar, we delve into the integration of artificial intelligence in enhancing PET imaging for Alzheimer's diagnosis and care.

Key Topics Covered:

- The introduction of Nuclivision and its innovative product, Nuclarity, designed to significantly improve PET imaging quality while reducing costs and scan times.
- An examination of whether AI models trained on whole-body imaging can effectively apply to brain scans, a critical question for advancing neuroimaging techniques.
- The potential of five-minute amyloid scans to match the quality of traditional twenty-minute scans, providing a pathway to increased patient accessibility.
- Insights into reducing radiotracer doses and optimizing acquisition times, ensuring patient safety and operational efficiency in nuclear medicine departments.

Key Takeaways:

‍
- Learn how AI can address the rising demand for nuclear medicine amidst operational constraints.
- Discover how Nuclivision's solutions make imaging more affordable and accessible, ultimately benefiting patient care.
- Gain a deeper understanding of the significance of amyloid PET imaging in the context of anti-amyloid therapies and the importance of robust quantitative measures.

This webinar presents a unique opportunity for nuclear medicine professionals to stay ahead in a rapidly evolving field, enhancing their knowledge and operational capabilities. Don't miss this chance to learn from leading experts and engage with cutting-edge research that could redefine patient care in nuclear medicine.

‍